These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15294416)

  • 1. Sensitivity analysis of a nonlinear lumped parameter model of HIV infection dynamics.
    Bortz DM; Nelson PW
    Bull Math Biol; 2004 Sep; 66(5):1009-26. PubMed ID: 15294416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay.
    Culshaw RV; Ruan S; Webb G
    J Math Biol; 2003 May; 46(5):425-44. PubMed ID: 12750834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV-1 quantitative dynamics in vivo: a review of mathematical models].
    Le Corfec E; Rouzioux C; Costagliola D
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):168-81. PubMed ID: 10804426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HIV-1 kinetic models using quantitative discrimination analysis.
    Knorr AL; Srivastava R
    Bioinformatics; 2005 Apr; 21(8):1668-77. PubMed ID: 15613395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo estimates of natural variation in HIV infection.
    Heffernan JM; Wahl LM
    J Theor Biol; 2005 Sep; 236(2):137-53. PubMed ID: 16005307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy.
    Liu S; Wang L
    Math Biosci Eng; 2010 Jul; 7(3):675-85. PubMed ID: 20578792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.
    Bermejo M; Sánchez-Palomino S; Usán L; Alcamí J
    J Med Virol; 2004 Aug; 73(4):502-7. PubMed ID: 15221892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of delays in cell infection and virus production on HIV-1 dynamics.
    Zhu H; Zou X
    Math Med Biol; 2008 Jun; 25(2):99-112. PubMed ID: 18504248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of equilibria and effects of drug treatments in some simple viral population dynamical models.
    Tuckwell HC; Wan FY
    IMA J Math Appl Med Biol; 2000 Dec; 17(4):311-27. PubMed ID: 11270747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling viral and immune system dynamics.
    Perelson AS
    Nat Rev Immunol; 2002 Jan; 2(1):28-36. PubMed ID: 11905835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model selection and mixed-effects modeling of HIV infection dynamics.
    Bortz DM; Nelson PW
    Bull Math Biol; 2006 Nov; 68(8):2005-25. PubMed ID: 16900456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 dynamics at different time scales under antiretroviral therapy.
    García JA; Soto-Ramírez LE; Cocho G; Govezensky T; José MV
    J Theor Biol; 2006 Jan; 238(1):220-9. PubMed ID: 16005903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death.
    Funk GA; Oxenius A; Fischer M; Opravil M; Joos B; Flepp M; Weber R; Günthard HF; Bonhoeffer S
    J Med Virol; 2006 Sep; 78(9):1141-6. PubMed ID: 16847964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
    Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A
    Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication rate and evolution in the human immunodeficiency virus.
    Kelly JK
    J Theor Biol; 1996 Jun; 180(4):359-64. PubMed ID: 8776467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2004 Sep; 66(5):1259-83. PubMed ID: 15294425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.